|
J Biol Chem, Vol. 273, Issue 34, 22007-22013, August 21, 1998
ATP-dependent Desensitization of Insulin Binding and
Tyrosine Kinase Activity of the Insulin Receptor Kinase
THE ROLE OF ENDOSOMAL ACIDIFICATION*
Jean-Olivier
Contreres ,
Robert
Faure§¶,
Gerardo
Baquiran ,
John J.
Bergeron , and
Barry I.
Posner **
From the Polypeptide Hormone Laboratory, the
Department of Anatomy and Cell Biology, McGill University,
Montreal, Quebec H3A 2B2, Canada and the § Department de
Medecine et le Centre de Recherche du CHUL, Universite Laval, St. Foy,
Quebec G1V 4G2, Canada
 |
ABSTRACT |
Incubating endosomes with ATP decreased binding
of 125I-insulin but not 125I-labeled
human growth hormone. Increasing ATP concentrations from 0.1 to 1 mM increased -subunit tyrosine phosphorylation and
insulin receptor kinase (IRK) activity assayed after partial purification. At higher (5 mM) ATP concentrations
-subunit tyrosine phosphorylation and IRK activity were markedly
decreased. This was not observed with nonhydrolyzable analogs of ATP,
nor with plasma membrane IRK, nor with endosomal epidermal growth
factor receptor kinase autophosphorylation. The inhibition of endosomal IRK tyrosine phosphorylation and activity was completely reversed by
bafilomycin A1, indicating a role for endosomal proton
pump(s). The inhibition of IRK was not due to serine/threonine
phosphorylation nor was it influenced by the inhibition of
phosphotyrosyl phosphatase using
bisperoxo(1,10-phenanthroline)oxovanadate anion. Prior phosphorylation of the -subunit with 1 mM ATP did not prevent the
inhibition of IRK activity on incubating with 5 mM ATP. To
evaluate conformational change we incubated endosomes with
dithiothreitol (DTT) followed by SDS-polyacrylamide gel electrophoresis
under nonreducing conditions. Without DTT the predominant species of
IRK observed was 2 2. With DTT the 
dimer predominated but on co-incubation with 5 mM ATP the
2 2 form predominated. Thus,
ATP-dependent endosomal acidification contributes to the
termination of transmembrane signaling by, among other processes,
effecting a deactivating conformational change of the IRK.
 |
INTRODUCTION |
Following insulin binding to its receptor in intact cells the
insulin receptor kinase
(IRK)1 undergoes tyrosine
autophosphorylation and kinase activation (1, 2). Equally rapidly there
is internalization of activated insulin-IRK complexes into ENs (3, 4).
IRK signaling appears largely to involve tyrosine phosphorylation of
adaptor proteins, including insulin receptor substrate-1 (5), insulin
receptor substrate-2 (6, 7), and SHC (8), which function as docking entities to entrain the insulin signaling sequence. The observation that the activated IRK is internalized to ENs is consistent with the
occurrence of transmembrane signaling intracellularly (9, 10). Indeed
studies in liver parenchyma have shown that the accumulation of
activated IRKs exclusively in ENs is sufficient to promote insulin
receptor substrate-1 tyrosine phosphorylation (11). In adipocytes it
has also been shown that internal membranes are the principal sites
where insulin receptor substrate-1 phosphorylation and
phophatidylinositol 3-kinase activation occur (12).
Given the above, understanding the mechanisms controlling receptor
function in ENs is important for understanding the regulation of
insulin signaling. Studies have shown that the level of IRK tyrosine
phosphorylation and hence activity is altered and ultimately reduced by
an IRK-associated phosphotyrosine phosphatase in ENs (4, 13). Discovery
of the endosomal acidic insulinase (14) has demonstrated a mechanism by
which intraendosomal insulin concentration may be reduced, hence
decreasing the proportion of IRKs occupied by ligand (15). In a
cell-free system it was demonstrated that ATP-dependent
endosomal acidification promoted both insulin dissociation from the IRK
and subsequent degradation of free insulin by the endosomal acidic
insulinase (15-17). In the present study we report that
ATP-dependent endosomal acidification also leads to
decreased IRK binding capacity and to marked deactivation of IRK
activity toward exogenous substrates. Our data indicate that this
latter phenomenon derives from an acidification dependent
conformational change in the intraluminal aspect of the endosomal IRK
with attendant deactivation of the cytosolic tyrosine kinase. These
data thus identify another process leading to attenuation of the
activated state of the IRK, and hence transmembrane signaling during
the course of endocytosis.
 |
MATERIALS AND METHODS |
Animals--
Female Sprague-Dawley rats (140-160-g body weight)
were purchased from Charles River Ltd. (St. Constant, Quebec) and were fasted overnight prior to killing.
Reagents--
Porcine insulin (26.8 IU/mg) was a gift from Eli
Lilly Research Laboratories. Human growth hormone (hGH, 2.2 IU/mg was
from the NIH pituitary hormone and antisera program (Baltimore, MD). Carrier-free [125I]iodine and [ -32P]ATP
(1000-3000 Ci/mmol) were purchased from NEN Life Science Products.
NaCl, MgSO4, trichloroacetic acid, and glycerol were from
Anachaemia Ltd. (Lachine, Quebec). Wheat germ agglutinin (WGA)-Sepharose 6-MB and protein A-Sepharose were from Amersham Pharmacia Biotech (Dorval, Quebec). Nucleosides tri-, di-, and monophosphates, AMP-PCP, AMP-PNP, and AMP-PSP were from Boehringer Mannheim. Chemicals for SDS-PAGE were from Bio-Rad. Kodak X-Omat AR
films were purchased from Picker International Canada (Montreal, Quebec). Immobilon was from Millipore Canada Ltd. (Mississauga, ON).
Bafilomycin A1, poly(Glu, Tyr) (4:1),
N-acetyl-D-glucosamine, and other chemicals were
from Sigma. The peroxovanadium compound bpV(phen) was synthesized and
purified as previously reported (18).
Antibodies--
Antibody to the juxtamembrane domain (residues
942-968) of the insulin receptor ( 960) and to phosphotyrosine were
prepared and purified as described previously (4). Affinity-purified goat anti-rabbit antibodies (whole molecule) were purchased from Sigma
and iodinated to a specific activity of 6 × 108
dpm/µg of IgG using a chloramine T procedure (19).
Subcellular Fractions, Binding, and Protein
Determination--
Rats were anaesthetized with ether and were
injected via jugular vein with a dose (per 100 g of body weight)
of insulin (1.5 µg), or bpV(phen) (0.6 µmol), dissolved in 0.2 ml
of phosphate-buffered saline (pH 7.4), 0.1% bovine serum albumin.
Animals were killed by decapitation at 2 and 15 min postinjection of
insulin and bpV(phen), respectively (13). Livers were rapidly excised,
placed in ice-cold homogenizing buffer (50 mM HEPES (pH
7.4), 0.25 m sucrose, 1 mM phenylmethylsulfonyl
fluoride, 1 mM MgCl2, 1 mM
benzamidine) and minced before homogenization. Combined ENs and PM
fractions were prepared as described previously (3) except that the
buffer used throughout was that in which the livers were minced (see above). These subcellular fractions have been characterized in detail
both morphologically and biochemically (3, 20-23). Hormone binding was
assayed with 125I-insulin or 125I-labeled hGH
prepared to a specific activity of 100-200 µCi/µg using the
chloramine-T method as described previously (19). Protein content in
the fractions was determined by a modification of Bradford's method
using serum albumin as a standard (24).
Insulin Receptor Phosphotyrosine Content--
The
phosphotyrosine content of endosomal insulin receptors was determined
by subjecting WGA-purified preparations to SDS-PAGE and immunoblotting
with 960 and PY as described previously (4).
Insulin Receptor Kinase Assays--
Insulin receptors from
subcellular fractions were partially purified by chromatography on
WGA-Sepharose 6MB columns, and receptor content and tyrosine kinase
activity were measured as described previously (3, 4, 20). It has been
previously shown that, after insulin administration, tyrosine kinase
activity of WGA-purified endosomal preparations was at least 90%
attributable to the IRK (4).
Insulin Receptor Autophosphorylation and Phosphoamino Acid
Analyses--
ENs were removed from the 0.6/1.0 m sucrose interface of
the gradient used in endosomal purification (20) and diluted with 0.25 M sucrose to a final protein concentration of 50 µg/ml. A 30-ml aliquot was centrifuged at 200,000 × gav for 40 min prior to resuspending in 500 µl
of cell-free system buffer (44 mM HEPES (pH 7.4), 0.55 M sucrose, 333 mM KCl, 11 mM NaCl,
11 mM MgCl2). Incubations were initiated by
adding 500 µl of 10 mM Tricine buffer containing either 2 or 10 mM ATP at a specific activity of 0.5 mCi of
32P/mmol. After incubating for 15 min at 37 °C the
reaction was stopped by adding an equal volume of ice-cold 20 mM HEPES, 0.25 M sucrose, 2 mM
phenylmethylsulfonyl fluoride, 2 mM benzamidine, 4 mM sodium orthovanadate, and 80 mM sodium
fluoride. ENs were solubilized by incubating for an additional 30 min
at 4 °C in a final concentration of 1% Triton X-100, 20 mM pepstatin, 20 mM leupeptin, and 10 mg/ml
aprotinin, after which IRKs were immunoprecipitated with 960, washed
in buffer, subjected to SDS-PAGE, transferred to Immobilon-P membranes,
and subjected to autoradiography and/or amino acid analyses as
described previously (25).
Insulin Receptor under Nonreducing Conditions--
Endosomal
pellets were resuspended (500 µg of protein/ml) in a final
concentration of 50 mM Tris (pH 6.9), 10% glycerol, and 20 mM N-ethylmaleimide. Samples were incubated at
room temperature for 5 min and then solubilized without heating in
2.3% SDS, 0.05% bromphenol blue before subjecting to SDS-PAGE in the
absence of reductants as described previously (26).
EGF Receptor Autophosphorylation in the Presence and Absence of
ATP--
EGF (10 µg/100 g of body weight) was injected via the
jugular vein into anesthetized rats. The animals were sacrificed by decapitation 15 min later, and ENs were prepared as noted above. Resuspended ENs were incubated for 15 min with 5 mM ATP
after which autophosphorylation was initiated by adding
[32P]ATP. The reaction was stopped after 15 min of
incubation at 37 °C by adding Laemmli sample buffer after which
aliquots (100 µg of protein) were subjected to SDS-PAGE, alkali
digestion, and radioautography as described previously (13).
 |
RESULTS |
Following in vivo administration,
125I-insulin concentrates in ENs attained maximum levels at
2 min postinjection (19, 23, 27). When subsequently incubated in
vitro, intraendosomal 125I-insulin undergoes
dissociation from its receptor and degradation in a temperature and
ATP-dependent manner (15). Previous work showed that this
insulin degradation was effected by a relatively specific endosomal
acidic insulinase (14, 15).
Effect of ATP on Insulin Binding and IRK Activity
In the present study we continued to evaluate the processes
involved in reducing the association of intraendosomal insulin with its
receptor. We examined the effect of incubating intact ENs with ATP on
subsequently measured insulin and hGH binding in both solubilized and
WGA-purified receptors. Table I
illustrates that, at increasing ATP concentrations (0.1, 1, 3, 5, and
10 mM), there was a progressive decrease of insulin but not
hGH binding. The decrease of insulin binding was not produced by ADP,
AMP, sodium pyrophosphate, adenosine, or nonhydrolyzable ATP analogs (Table II). The loss of binding activity
was temperature-dependent, as no changes were observed when
ENs were incubated on ice in the presence of 10 mM ATP
(Table II). These data strongly suggest that the
ATP-dependent effect was specific for insulin and
necessitated hydrolysis of the -phosphate of ATP.
View this table:
[in this window]
[in a new window]
|
Table I
The effect of preincubating ENs with increasing ATP concentrations on
125I-insulin and 125I-labeled hGH binding
ENs from insulin-injected rats were preincubated with ATP at 37 °C
for 15 min, solubilized, and assayed for insulin or hGH binding before
and after WGA purification as described under "Materials and
Methods." Specific binding was expressed as a percent of that in
control ENs preincubated without ATP. Binding in control ENs was:
solubilized ENs (per 50 µg of protein)-insulin, 16.6 ± 3.1%
(n = 13); hGH, 15.2 ± 1.7% (n = 3); WGA-purified (per 1 µg of protein)-insulin, 17.4 ± 4.9%
(n = 6); hGH, 11.4 ± 1.0 (n = 3).
Values are the means ± S.D.
|
|
View this table:
[in this window]
[in a new window]
|
Table II
The effect of different nucleotides on endosomal
125I-insulin binding activity
Results are the mean of two to five experiments ± S.D. Endosomes
from insulin-injected rats were preincubated with the noted
concentration of nucleotides at 37 °C for 15 min, solubilized, and
assayed for insulin binding before and after WGA purification as
described under "Materials and Methods." The specific binding
observed was normalized to those levels obtained with endosomes
preincubated without nucleotide. All values are the means ± S.D.
|
|
Preincubating ENs with ATP also influenced IRK activity and
phosphotyrosine content (Fig. 1). In the
absence of ATP, IRK activity reflected the effect of preinjected
insulin (3, 4, 18). At 0.1 and 1.0 mM ATP there was an
increase, whereas at 5 mM ATP there was a marked decrease
in IRK activity even to a level below that observed in the absence of
ATP. At 10 mM ATP, IRK activity was virtually abolished.
IRK phosphotyrosine content was markedly increased on incubating ENs
with 1 mM ATP (Fig. 1B), whereas at 5 and 10 mM ATP this was significantly reduced and virtually
abolished, respectively, without affecting -subunit levels.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 1.
Effect on IRK activity of incubating intact
ENs with ATP. Rats were injected with insulin (1.5 µg/100 g of
body weight) and sacrificed after 2 min. Fresh hepatic ENs were
incubated for 15 min at 37 °C with ATP at the indicated
concentration. IRK was purified from solubilized ENs by WGA-Sepharose
chromatography as indicated under "Materials and Methods."
Panel A, effect of ATP on IRK activity. Equal amounts of
WGA-purified IRK were assayed for exogenous tyrosine kinase activity
using poly(Glu, Tyr) (4:1) as substrate. Exokinase activity was
expressed as picomoles/10 min/10 fmol of insulin binding. Each point
reflects the mean ± S.E. of determination from four to six
separate experiments. Panel B, effect of ATP on -subunit
phosphotyrosine content. WGA eluates (5 µg of protein) were subjected
to SDS-PAGE in 7.5% gels followed by transfer of proteins to
Immobilon-P membranes. Membranes were probed with PY or 960
antibodies followed by incubation with 125I-GAR as a second
antibody and exposed for autoradiography.
|
|
To verify the importance of the high energy bond of ATP in producing
the above changes, we incubated ENs with 0 and 1 mM ATP in
the presence (5 mM) or absence of the nonhydrolyzable ATP
analog, AMP-PCP. No effect of 5 mM AMP-PCP either in the
presence or absence of 1 mM ATP was found (Fig.
2). The effect of the analog to reduce IRK phosphotyrosine concentration to a modest extent may reflect some
inhibition of IRK autophosphorylation.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 2.
Absence of inhibitory effect of
nonhydrolyzable ATP analogs on IRK activity. Rats were sacrificed
2 min following insulin injection (1.5 µg/100 g of body weight).
Fresh hepatic ENs were incubated for 15 min at 37 °C with ATP in the
absence or presence of 5 mM AMP-PCP. ENs were solubilized
and IRK purified by WGA-Sepharose chromatography as noted under
"Materials and Methods." Panel A, effect of AMP-PCP on
IRK activity. WGA- purified IRK was assayed for activity using
poly(Glu, Tyr) (4:1) as a substrate. Exokinase activity was expressed
as picomoles/10 min/10 fmol insulin binding. Panel B, effect
of AMP-PCP on the -subunit phosphotyrosine content. WGA eluates (5 µg of protein) were subjected to SDS-PAGE in 7.5% gels. Proteins
were transferred to Immobilon-P membranes, which were probed with PY
antibody followed by incubation with 125I-GAR and exposed
for autoradiography.
|
|
To determine whether ATP-dependent attenuation of IRK
activation is specific to the endosomal compartment, we preincubated PM
with ATP and observed an augmentation of WGA-purified IRK activity (Fig. 3A). At 10 mM ATP the increase in PM IRK activity was greater than
that observed at 1 mM in sharp contrast to what was found in ENs where preincubation with 10 mM ATP suppressed IRK
activity completely.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 3.
A, effect on IRK activity of
incubating PM and ENs with ATP. Fresh hepatic PM and EN fractions,
prepared at 30 s and 2 min post insulin (1.5 µg/100 g of body
weight), were incubated for 15 min at 37 °C with ATP at the
indicated concentrations. Cell fractions were solubilized, and IRK,
purified by WGA-Sepharose chromatography, was assayed for activity
using poly(Glu, Tyr) (4:1) as noted under "Materials and Methods."
Exokinase activity was expressed as picomoles/10 min/10 fmol of insulin
binding. B, effect on EGF receptor autophosphorylation of
incubating ENs with ATP. ENs, prepared 15 min after EGF injection (10 µg/100 g of body weight), were incubated in the presence or absence
of ATP (5 mM) prior to conducting autophosphorylation with
[32P]ATP, SDS-PAGE, and autoradiography as described
under "Materials and Methods."
|
|
Preincubation with ATP did not attenuate EGF receptor
autophosphorylation. Thus incubating ENs from EGF-treated rats with 5 mM ATP did not significantly reduce
32P-labeling of the EGF receptor (Fig. 3B).
Role of Endosomal Acidification
Various studies have established that in ENs there is a
progressive luminal acidification through the action of
ATP-dependent proton pumps (28-31). To evaluate the role
of ATP-dependent acidification on the IRK activation state
we incubated ENs with bafilomycin A1, a potent inhibitor of
endosomal ATPases (31), in the presence and absence of ATP. As noted in
Fig. 4A coincubation with
bafilomycin produced a marked attenuation in the ability of 5 and 10 mM ATP to effect a reduction in IRK activation. Furthermore
in the presence of bafilomycin the level of IRK tyrosine
phosphorylation at 5 mM ATP was comparable to that observed
at 1 mM ATP (Fig. 4B).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 4.
Effect of the ATPase inhibitor, bafilomycin,
on the ATP-dependent deactivation of endosomal IRK
activity. Hepatic ENs, prepared 2 min post insulin (1.5 µg/100 g
of body weight), were preincubated in the absence or presence of 1 µM bafilomycin A1. After 30 min at 37 °C
the incubation was continued for 15 min with ATP at the indicated
concentrations. Panel A, effect of bafilomycin
A1 on ATP-dependent inhibition of IRK activity.
WGA-purified IRK tyrosine kinase activity was assayed using poly(Glu,
Tyr) (4:1) as substrate and expressed as a percent of that obtained
from incubations conducted without ATP. IRK activity from incubations
with or without bafilomycin A1, and before ATP additions,
were 1.4 and 1.3 pmol/10 min/10 fmol of insulin binding, respectively.
Panel B, effect of bafilomycin on ATP-dependent
regulation of IRK -subunit autophosphorylation. WGA eluates (5 µg
of protein) were subjected to SDS-PAGE in 7.5% gels followed by
transfer of proteins to Immobilon-P membranes. The membranes were then
probed with PY or 960 antibodies followed by 125I-GAR
and autoradiography. The same findings were made in three repeat
experiments.
|
|
Studies on Attenuation of IRK Activation
We subsequently sought to determine the mechanism by which
ATP-dependent endosomal acidification results in diminution
of the IRK activation state.
Serine/Threonine Phosphorylation--
Previous work demonstrated
that serine/threonine phosphorylation of the -subunit of the IRK
results in inhibition of IRK activity (32, 33). We thus determined if
ATP promotes the phosphorylation of IRK on serine and threonine
residues by incubating ENs with 1 or 5 mM
[ -32P]ATP (0.5 mCi/mmol). IRKs were subsequently
purified by immunoprecipitation and SDS-PAGE and subjected to
two-dimensional phosphoamino acid analyses of the -subunit. The IRK
showed no detectable [32P]phosphoserine from either the 1 or 5 mM ATP incubations (Fig. 5).

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 5.
Phosphoamino acid analyses of the IRK
-subunit after incubating intact ENs with 1 and 5 mM
[ -32P]ATP. Hepatic ENs, prepared 2 min
following insulin (1.5 µg/100 g of body weight), were incubated for
15 min at 37 °C with 1 or 5 mM
[ -32P]ATP (0.5 mCi/mmol), solubilized, and
immunoprecipitated with 960 antibodies. Immunoprecipitates were
resolved on SDS-PAGE and transferred to Immobilon-P membranes as noted
under "Materials and Methods." Regions of the Immobilon-P membranes
containing the IRK -subunit were localized by autoradiography,
excised, and subjected to acid hydrolysis to release phosphoamino
acids, which were separated by two-dimensional thin layer
electrophoresis as described under "Materials and Methods." Thin
layer electrophoresis was performed using equal amounts of
32P label (500 cpm) and phosphoserine (pS),
phosphothreonine (pT), and phosphotyrosine (pY),
which were localized by ninhydrin staining. A second experiment yielded
comparable results.
|
|
Activation of Phosphotyrosyl Phosphatase(s)--
To assess whether
higher ATP concentrations might promote activation of endosomal
phosphotyrosyl phosphatases and effect a reduction in the
phosphotyrosine content of the IRK -subunit, we blocked
phosphotyrosyl phosphatase activity using bpV(phen), a potent
phosphotyrosyl phosphatase inhibitor (18). Coincubating ENs with
bpV(phen) did not prevent the marked suppression of IRK activity seen
in the presence of 5 mM ATP (Fig.
6). Furthermore, the augmented IRK
activity in ENs isolated from rats pretreated with bpV(phen) was
also suppressed on incubating these ENs with 5 mM ATP. Nor
did bpV(phen) influence the reduction observed in -subunit tyrosine
phosphorylation seen in the presence of 5 mM ATP (Fig.
6B). We conclude that phosphotyrosyl phosphatase activity plays no role in effecting a reduction of endosomal IRK function at
higher ATP concentrations.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of inhibiting phosphotyrosyl
phosphatase activity by bpV(phen) on ATP-dependent changes
in endosomal IRK activity. Hepatic ENs, prepared at 2 or 15 min
after insulin (1.5 µg/100 g of body weight) or bpV(phen) (0.6 µmol/100 g of body weight) respectively, were incubated for 15 min at
37 °C with ATP in the absence or presence of 0.1 mM
bpV(phen). ENs were solubilized and IRK purified by WGA-Sepharose
chromatography as described under "Materials and Methods."
Panel A, effect of different ATP concentrations on IRK
activity. WGA-purified IRK preparations were assayed for activity using
poly(Glu, Tyr)(4:1) as substrate. Exokinase activity was expressed as
picomoles/10 min/10 fmol of insulin binding. Panel B, effect
of different ATP concentrations on IRK -subunit phosphotyrosine
content. WGA eluates (5 µg of protein) were subjected to SDS-PAGE in
7.5% gels, transferred to Immobilon-P membranes, which were probed
sequentially with PY and 125I-GAR followed by
autoradiography. Comparable results were observed in three separate
studies.
|
|
Dissociation of IRK Activity and its Autophosphorylation
State--
To determine the relationship between IRK activity and
-subunit tyrosine phosphorylation we preincubated ENs with 1 or 5 mM ATP for 15 min followed by a second incubation with 5 mM ATP. As observed in Fig. 7
preincubation with 1 mM ATP followed by a second incubation
with 5 mM ATP resulted in marked reduction of IRK activity
in the presence of a substantial retention of its phosphotyrosine
content. Sequential incubations in 1 mM ATP had no
deleterious effect on either IRK activity or phosphotyrosine content.
Thus endosomal acidification results in the inactivation of an
autophosphorylated IRK.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 7.
Inhibition by ATP of the kinase activity of
endosomal IRK is independent of the state of -subunit tyrosine
phosphorylation. Hepatic ENs, prepared 2 min after insulin (1.5 µg/100 g of body weight), were incubated for 15 min at 37 °C with
0, 1, or 5 mM ATP followed by a second 15-min incubation
with ATP at the indicated concentrations. ENs were solubilized, and IRK
were purified by WGA-Sepharose chromatography. Panel A,
phosphotyrosine content of the -subunit of the insulin receptor. WGA
eluates (5 µg of protein) were subjected to SDS-PAGE in 7.5% gels.
Proteins were transferred to Immobilon-P membranes and probed with
PY or 960 antibodies and 125I-GAR as second antibody
prior to autoradiography. Panel B, IRK activity.
WGA-purified IRK activity was assayed, using poly(Glu, Tyr) (4:1) as
substrate, and expressed as picomoles/10 min/10 fmol of insulin
binding. Comparable results were seen in a second experiment.
|
|
Evidence for an Acidification-dependent Conformational
Change of the Endosomal IRK
The above observation suggested that intraluminal events were
responsible for deactivation of the endosomal IRK. To determine whether
there might be a conformational change in the IRK consequent to
ATP-dependent acidification we incubated ENs with ATP in
the presence or absence of 10 mM DTT to assess the ease
with which type I disulfide bonds might be reduced in the
heterotetrameric molecule ( 2 2). After
incubating in the presence or absence of 5 mM ATP the
heterotetramer was readily identified (Fig.
8, lanes 1 to 3).
When the incubation contained 10 mM DTT, the heterotetramer was readily reduced to the heterodimer ( ) in the absence but not
the presence of 5 mM ATP (lane 4 versus 5). Thus, consequent to
ATP-dependent acidification of endosomes, there is a change in -subunit conformation which renders the type I disulfide bonds relatively resistant to reduction by DTT.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 8.
Effect of ATP on DTT-dependent
reduction of endosomal IRK species. Hepatic ENs, prepared 2 min
after insulin (1.5 µg/100 g of body weight), were incubated for 15 min at 37 °C in the absence or presence of 10 mM DTT and
5 mM ATP. ENs were centrifuged, resuspended, and treated as
described under "Materials and Methods." Samples were applied
without heating to SDS-PAGE (gradient resolving gel, 3-10%
acrylamide) in the absence of reductant. Proteins were transferred to
Immobilon-P membranes and probed with 960 and 125I-GAR
antibodies prior to autoradiography. The same finding was made in three
separate experiments.
|
|
 |
DISCUSSION |
The endosomal apparatus consists of a series of distinct
tubulovesicular components involved in the uptake and sorting of ligand-receptor complexes (34, 35). The ENs employed in these studies
have been previously characterized and shown to contain Golgi elements
but to be substantially free of plasma membrane and other subcellular
constituents (19, 20, 36-38). The addition of ATP to these ENs
augments both dissociation and degradation of internalized insulin (15)
due to stimulation of an ATP-dependent proton pump. The
resulting acidification (pH 5.5) of the intraendosomal milieu activates
a relatively specific insulin protease (i.e. endosomal
acidic insulinase) (14-17, 27, 39, 40). The coupling of dissociation
at acid pH with insulin degradation facilitates removal of internalized
receptor-bound insulin. However, given the small volume of an endocytic
vesicle ( 10 17 liter) (41), the extent of dissociation
of insulin from its receptor might be expected to be limited even at pH
5.5-6.0.
We thus considered that other mechanism(s) for abrogating IRK
activation in ENs might exist. Indeed incubating ENs with ATP resulted
in a loss of insulin receptor binding capacity. This effect was
specific for the IRK since no decrease in binding was observed for hGH
(Table I). The loss of insulin binding was not observed at 4 °C, and
the presence of the -phosphate of ATP was necessary since no
inhibition occurred with adenosine, AMP, ADP, and sodium pyrophosphate.
The presence of a high energy bond was necessary as nonhydrolyzable ATP
analogs were unable to produce the effect (Table II). The reduction of
insulin binding activity represents another mechanism for sustaining
the dissociation-degradation sequence for insulin in ENs.
An ATP-dependent process is implicated in deactivation of
the IRK within ENs. Although IRK activity and -subunit
phosphotyrosine content increased in parallel at 0.1 and 1 mM ATP, they were both reduced at higher ATP concentrations
(Fig. 1). This was not due to proteolysis of the -subunit since none
was lost in these experiments. The effect requires the high energy bond
of ATP, and was unique to the endosomal compartment since PM IRK
activity was not suppressed at high ATP concentrations. ENs have a
slightly acidic interior maintained by an ATP-dependent
proton pump (15, 30, 31). The observation that
ATP-dependent inhibition of IRK activity was reversed
by bafilomycin (Fig. 4) strongly supports the idea that proton pump
acidification of ENs is critical to this process. It is noteworthy that
the levels of ATP promoting IRK inhibition approximate estimated
intracellular concentrations (42-44).
We explored the mechanism by which ATP-dependent endosomal
acidification effects inactivation of the IRK. Since serine/threonine phosphorylation of the IRK has been show to reduce IRK activation (28,
29, 45), we examined the phosphoamino acid content of the endosomal IRK
incubated in the presence of 1 versus 5 mM ATP.
Two-dimensional phosphoamino acid analyses showed that serine/threonine phosphorylation of IRK was not augmented at higher ATP concentrations. The marked reduction in phosphotyrosine content of the IRK at 5 mM ATP was not a consequence of augmented phosphotyrosyl
phosphatase activity, since bpV(phen) did not antagonize the inhibitory
effect of 5 mM ATP on either IRK phosphotyrosine content or
activity.
The ATP inhibitory effect was shown to be independent of the
phosphorylation state of the -subunit (Fig. 7), suggesting that an
intrinsic defect in IRK function secondary to a conformational change
might explain our observations. Indeed the ability of DTT to reduce
tetrameric IRK molecules was significantly decreased subsequent to the
incubation of ENs with 5 mM ATP (Fig. 8). The reduced
susceptibility of the type I disulfide bond between the - and
-subunits to DTT implies the occurrence of a
pH-dependent modification of the IRK. We suggest that a
conformational change of the IRK, effected by the
ATP-dependent intraluminal drop in pH, was transmitted to
its cytosolic domain producing decreased IRK activity. This is
consistent with crystallographic studies (46, 47) suggesting that,
whereas activation of IRK occurs through a trans-autophosphorylation
reaction, deactivation occurs through a cis-intramolecular mechanism
(cis-inhibition) (46). The presumed change in the intraluminal portion
of the IRK may be responsible for the observed decrease in insulin
binding (cf. Table I).
This study indicates that the regulation of endosomal IRK activity is
multifaceted and that the deactivation involves several discrete
components. Previous work has shown that insulin signaling occurs from
the endosomal system (9-11). The present study supports the view that
there is a temporal window of signaling delimited in part by
progressive acidification of ENs due to the activity of
ATP-dependent proton pumping. Endosomal acidification
contributes to IRK inactivation by: 1) promoting insulin dissociation
from the IRK, 2) activating endosomal acidic insulinase, 3) decreasing the binding capacity of IRK, and 4) altering the conformation of the
IRK thus reducing intrinsic activity.
Other studies have documented the importance of endosomal acidification
in regulating a range of biological processes. Vesicular stomatitis and
rabies viruses enter cells through receptor-mediated endocytosis but
are rendered competent to enter cytosol after accessing the low pH of
ENs. In this environment the viral envelope undergoes a conformational
transition permitting fusion of viral membrane with endosomal membranes
(48, 49). This transition involves the exposure of a hydrophobic
segment within the glycoprotein whose ability to interact with
membranes effects fusion and extrusion of the viral core through the
wall of ENs (49). Low pH-driven conformational changes in ENs have been
described for the diphtheria toxin and constitute a prerequisite for
the subsequent reduction of the diphtheria toxin interchain disulfide
bond, the rate-limiting step in translocation of toxin into cytosol
(50). Recent data suggest that a key determinant regulating
dephosphorylation and resensitization of the -adrenergic receptor is
the association of internalized receptor and phosphatase in a step
involving pH-sensitive conformational change(s) in receptor and/or
phosphatase (51).
The regulation of intraendosomal pH may play a role in modulating
insulin sensitivity in vivo (52-54) since, in type II
diabetic patients, the acidotropic agent chloroquine improved glucose
metabolism (55-61). Because chloroquine inhibits intraendosomal
insulin degradation it may be inferred that the endosomal accumulation
of intact insulin is responsible for the improved insulin sensitivity.
The present work raises the possibility that the metabolic effects of
chloroquine are due to an influence on IRK conformation and function.
Indeed it may be that pH-dependent disturbances in IRK
function contribute to the pathogenesis of type II diabetes
mellitus.
 |
ACKNOWLEDGEMENT |
We express our appreciation to Sheryl Jackson
for help with typing and editing the manuscript.
 |
FOOTNOTES |
*
This work was supported in part by the Medical Research
Council of Canada, the National Cancer Institute of Canada, the Fonds de Recherche du Quebec, and the Cleghorn Fund at McGill University.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Chercheur Boursier, Junior 2 of the Fonds de Recherche en
Sante du Quebec.
**
To whom correspondence should be addressed: Polypeptide Hormone
Laboratory, McGill University, Strathcona Anatomy and Dentistry Bdg.,
3640 University St., Rm. W315, Montreal, Quebec Canada. Tel.:
514-398-4101; Fax: 514-398-3923; E-mail: mc85{at}musica.mcgill.ca.
The abbreviations used are:
IRK, insulin
receptor kinase; EN, endosome; WGA, wheat germ agglutinin; PM, plasma
membrane; bpV(phen), bisperoxo(1,10-phenanthroline)oxovanadate anion; PY, phosphotyrosine; Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl] glycinePAGE, polyacrylamide gel electrophoresishGH, human growth hormoneDTT, dithiothreitolEGF, epidermal growth factorAMP-PNP, adenosine
5'-( , -imino)triphosphateAMP-PCP, adenosine
5'-( , -methylene)/triphosphate AMP-PSP, adenosine
5'-(3-thiophosphate)GAR, goat anti-rabbit antibody.
 |
REFERENCES |
-
Rosen, O. A.
(1987)
Science
237,
1452-1458[Abstract/Free Full Text]
-
Lee, J.,
and Pilch, P. F.
(1994)
Am. J. Physiol.
266,
C319-C334[Abstract/Free Full Text]
-
Khan, M. N.,
Baquiram, G.,
Brulé, C.,
Burgess, J.,
Foster, B.,
Bergeron, J. J. M.,
and Posner, B. I.
(1989)
J. Biol. Chem.
264,
12931-12940[Abstract/Free Full Text]
-
Burgess, J. W.,
Wada, I.,
Ling, N.,
Khan, M. N.,
Bergeron, J. J. M.,
and Posner, B. I.
(1992)
J. Biol. Chem.
267,
10077-10086[Abstract/Free Full Text]
-
Myers, M. G.,
and White, M. F.
(1993)
Diabetes
42,
643-650[Abstract]
-
Araki, E.,
Lipes, M. A.,
Patti, M. E.,
Bruning, J. C.,
Haag, B.,
Johnson, R. S.,
and Kahn, C. R.
(1995)
Nature
372,
186-190
-
Tobe, K.,
Tamemoto, H.,
Yamauchi, T.,
Aizawa, S.,
Yazaki, Y.,
and Kadowaki, T.
(1995)
J. Biol. Chem.
270,
5698-5701[Abstract/Free Full Text]
-
Sasoaka, T.,
Draznin, B.,
Leitner, J. W.,
Langlois, W. J.,
and Olfesky, J. M.
(1994)
J. Biol. Chem.
269,
10734-10738[Abstract/Free Full Text]
-
Bevan, A. P.,
Drake, P. G.,
Bergeron, J. J. M.,
and Posner, B. I.
(1996)
Trends Endocrinol. Metab.
7,
13-21
-
Baass, P. C.,
Di Guglielmo, G. M.,
Authier, F.,
Posner, B. I.,
and Bergeron, J. J. M.
(1995)
Trends Cell Biol.
5,
465-470[CrossRef][Medline]
[Order article via Infotrieve]
-
Bevan, A. P.,
Burgess, J. W.,
Drake, P. G.,
Shaver, A.,
Bergeron, J. J. M.,
and Posner, B. I.
(1995)
J. Biol. Chem.
270,
10784-10791[Abstract/Free Full Text]
-
Kublaoui, B.,
Lee, J.,
and Pilch, P. F.
(1995)
J. Biol. Chem.
270,
59-65[Abstract/Free Full Text]
-
Faure, R.,
Baquiran, G.,
Bergeron, J. J. M.,
and Posner, B. I.
(1992)
J. Biol. Chem.
267,
11215-11221[Abstract/Free Full Text]
-
Authier, F.,
Rachubinski, R. A.,
Posner, B. I.,
and Bergeron, J. J. M.
(1994)
J. Biol. Chem.
269,
3010-3016[Abstract/Free Full Text]
-
Doherty, J. J.,
Kay, D. G.,
Lai, W. H.,
Posner, B. I.,
and Bergeron, J. J. M.
(1990)
J. Cell Biol.
110,
35-42[Abstract/Free Full Text]
-
Backer, J. M.,
Kahn, C. R.,
and White, M. F.
(1990)
J. Biol. Chem.
265,
14828-14835[Abstract/Free Full Text]
-
Authier, F.,
Posner, B. I.,
and Bergeron, J. J. M.
(1994)
Cellular Proteolytic Systems, pp. 89-113, Wiley-Liss, New York
-
Posner, B. I.,
Faure, R.,
Burgess, J. W.,
Bevan, P. A.,
Lachance, D.,
Zhang-Sung, G.,
Fantus, I. G.,
Ng, J. B.,
Hall, D. A.,
Lum, B. S.,
and Shaver, A.
(1994)
J. Biol. Chem.
269,
4596-4604[Abstract/Free Full Text]
-
Posner, B. I.,
Patel, B. A.,
Khan, M. N.,
and Bergeron, J. J. M.
(1982)
J. Biol. Chem.
257,
5789-5799[Free Full Text]
-
Khan, M. N.,
Savoie, S.,
Bergeron, J. J. M.,
and Posner, B. I.
(1986)
J. Biol. Chem.
261,
8462-8472[Abstract/Free Full Text]
-
Kay, D. G.,
Lai, W. H.,
Uchihashi, M.,
Khan, M. N.,
Posner, B. I.,
and Bergeron, J. J. M.
(1986)
J. Biol. Chem.
261,
8473-8480[Abstract/Free Full Text]
-
Lai, W. H.,
Cameron, P. H.,
Wada, I.,
Doherty, J. J.,
Kay, D. G.,
Posner, B. I.,
and Bergeron, J. J. M.
(1989)
J. Cell Biol.
109,
2741-2749[Abstract/Free Full Text]
-
Posner, B. I.,
Patel, B.,
Verma, A. K.,
and Bergeron, J. J. M.
(1980)
J. Biol. Chem.
255,
735-741[Free Full Text]
-
Khan, M. N.,
Savoie, S.,
Khan, R. J. l,
Bergeron, J. J. M.,
and Posner, B. I.
(1985)
Diabetes
34,
1025-1030[Abstract]
-
Boyle, W. J.,
Van Der Geer, P.,
and Hunter, T.
(1991)
Methods Enzymol.
201,
110-148[Medline]
[Order article via Infotrieve]
-
Boni-Schnetzler, M.,
Kaligian, A.,
DelVecchio, R.,
and Pilch, P. F.
(1988)
J. Biol. Chem.
263,
6822-6828[Abstract/Free Full Text]
-
Hamel, F. G.,
Posner, B. I.,
Bergeron, J. J. M.,
Frank, B. H.,
and Duckworth, W. C.
(1988)
J. Biol. Chem.
263,
6703-6708[Abstract/Free Full Text]
-
Fuchs, R.,
Schmidt, S.,
and Mellman, I.
(1983)
Proc. Natl. Acad. Sci. U. S. A.
86,
539-543
-
Galloway, C. J.,
Dean, G. E.,
Marsh, M.,
Rudnick, G.,
and Mellman, I.
(1983)
Proc. Natl. Acad. Sci. U. S. A.
80,
3334-3338[Abstract/Free Full Text]
-
Mellman, I.,
Fuchs, R.,
and Helenius, A.
(1986)
Annu. Rev. Biochem.
55,
663-700[CrossRef][Medline]
[Order article via Infotrieve]
-
Clague, M. J.,
Urbe, S.,
Aniento, F.,
and Gruenberg, J.
(1994)
J. Biol. Chem.
269,
21-24[Abstract/Free Full Text]
-
Takayama, S.,
White, M. F.,
and Kahn, C. R.
(1988)
J. Biol. Chem.
263,
3440-3447[Abstract/Free Full Text]
-
Stadtmauer, L.,
and Rosen, O. M.
(1986)
J. Biol. Chem.
261,
3402-3407[Abstract/Free Full Text]
-
Burgess, J. W.,
Bevan, P. A.,
Bergeron, J. J. M.,
and Posner, B. I.
(1992)
Exp. Clin. Endocrinol.
11,
67-78
-
Hopkins, C. R.,
Gibson, A.,
Shipman, M.,
and Miller, K.
(1990)
Nature
346,
335-339[CrossRef][Medline]
[Order article via Infotrieve]
-
Bergeron, J. J. M.,
Searle, N.,
Khan, M. N.,
and Posner, B. I.
(1986)
Biochemistry
25,
1756-1764[CrossRef][Medline]
[Order article via Infotrieve]
-
Bergeron, J. J. M.,
Rachubinsky, R. A.,
Sickstrom, R. A.,
Posner, B. I.,
and Paiement, J.
(1982)
J. Cell Biol.
92,
139-146[Abstract/Free Full Text]
-
Desbuquois, B.,
Janicot, M.,
and Dupuis, A.
(1990)
Eur. J. Biochem.
193,
501-512[Medline]
[Order article via Infotrieve]
-
Levy, J. R.,
and Olefsky, J. M.
(1988)
J. Biol. Chem.
263,
6101-6108[Abstract/Free Full Text]
-
Courtoy, P.
(1993)
Subcellular Biochemistry
19,
29-68
-
Trischitta, V.,
Vignerie, R.,
Roth, R. A.,
and Goldfine, I., D.
(1984)
Metabolism
33,
577-581[CrossRef][Medline]
[Order article via Infotrieve]
-
Miller, D., S.,
and Horowitz, S. B.
(1986)
J. Biol. Chem.
261,
13911-13915[Abstract/Free Full Text]
-
Meyer, R. A.,
Kushmeerick, M. J.,
and Brown, T. R.
(1982)
Am. J. Physiol.
242,
C1-C11[Abstract/Free Full Text]
-
Sussman, I.,
Erecinski, M.,
and Wilson, D. F.
(1980)
Biochim. Biophys. Acta
591,
209-223[Medline]
[Order article via Infotrieve]
-
Lewis, R. E.,
Volle, D. J.,
and Sanderson, S. D.
(1994)
J. Biol. Chem.
269,
26259-26266[Abstract/Free Full Text]
-
Hubbard, S., R.,
Wei, L.,
Ellis, L.,
and Hendrickson, W. A.
(1994)
Nature
372,
746-754[CrossRef][Medline]
[Order article via Infotrieve]
-
Wei, L.,
Hubbard, S. R.,
Hendrickson, W. A.,
and Ellis, L.
(1995)
J. Biol. Chem.
270,
8122-8130[Abstract/Free Full Text]
-
Gaudin, Y.,
Ruigrok, R. W. H.,
Knossow, M.,
and Flamand, A.
(1993)
J. Virol.
67,
1365-1372[Abstract/Free Full Text]
-
Durrer, P.,
Gaudin, Y.,
Ruigrok, R. W. H.,
Graf, R.,
and Brunner, J.
(1995)
J. Biol. Chem.
270,
17575-17581[Abstract/Free Full Text]
-
Papini, E.,
Rappuolli, R.,
Murgia, M.,
and Montecucco, C.
(1993)
J. Biol. Chem.
268,
1567-1574[Abstract/Free Full Text]
-
Krueger, K. M.,
Daaka, Y.,
Pitcher, J. A.,
and Lefkowitz, R. J.
(1997)
J. Biol. Chem.
272,
5-8[Abstract/Free Full Text]
-
Khan, M. N.,
Savoie, S.,
Khan, R. J.,
Bergeron, J. J.,
and Posner, B. I.
(1985)
Diabetes
34,
1025-1030
-
Desbuquois, B.,
Janicot, M.,
and Dupuis, A.
(1990)
Eur. J. Biochem.
193,
501-512
-
Bevan, A. P.,
Krook, A.,
Tikerpae, J.,
Seabright, P. J.,
Siddle, K.,
and Smith, G. D.
(1997)
J. Biol. Chem.
272,
26833-26840[Abstract/Free Full Text]
-
Blazar, B. R.,
Whitley, C. B.,
Kitabchi, A. E.,
Tsai, M. Y.,
Santiago, J.,
White, N.,
Stentz, F. B.,
and Brown, D. M.
(1984)
Diabetes
33,
1133-1137[Abstract]
-
White, N. J.,
Miller, K. D.,
Marsh, K.,
Berry, C. D.,
Turner, R. C.,
Williamson, D. H.,
and Brown, J.
(1987)
Lancet
1,
708-711[CrossRef][Medline]
[Order article via Infotrieve]
-
Smith, G. D.,
Amos, T. A.,
Mahler, R.,
and Peters, T. J.
(1987)
Br. Med. J. Clin. Res. Ed.
294,
465-467
-
Quatraro, A.,
Consoli, G.,
Ceriello, A.,
and Giugliano, D.
(1988)
Diabete Metab.
14,
666-667[Medline]
[Order article via Infotrieve]
-
Pasvol, G.,
Newton, C. R.,
Winstanley, P. A.,
Watkins, W. M.,
Peshu, N. M.,
Were, J. B.,
Marsh, K.,
and Warrell, D. A.
(1991)
Am. J. Trop. Med. Hyg.
45,
702-713
-
Powrie, J. K.,
Smith, G. D.,
Shojaee-Moradie, F.,
Sonksen, P. H.,
and Jones, R. H.
(1991)
Am. J. Physiol.
260,
E897-E904[Abstract/Free Full Text]
-
Ilarde, A.,
and Tuck, M.
(1994)
Drugs Aging
4,
470-491[Medline]
[Order article via Infotrieve]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Balbis, G. Baquiran, V. Dumas, and B. I. Posner
Effect of Inhibiting Vacuolar Acidification on Insulin Signaling in Hepatocytes
J. Biol. Chem.,
March 26, 2004;
279(13):
12777 - 12785.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Garamszegi, J. J. E. Dore Jr., S. G. Penheiter, M. Edens, D. Yao, and E. B. Leof
Transforming Growth Factor beta Receptor Signaling and Endocytosis Are Linked through a COOH Terminal Activation Motif in the Type I Receptor
Mol. Biol. Cell,
September 1, 2001;
12(9):
2881 - 2893.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-F. Gaulin, A. Fiset, S. Fortier, and R. L. Faure
Characterization of Cdk2-Cyclin E Complexes in Plasma Membrane and Endosomes of Liver Parenchyma. INSULIN-DEPENDENT REGULATION
J. Biol. Chem.,
May 26, 2000;
275(22):
16658 - 16665.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|